Replies to post #142 on Ocular Therapeutix Inc (OCUL)

[budgetthis]

Canter Fitzgerald says the manufacturing "items of concern are addressable and shouldn't delay the product launch...."

They reiterated their Overweight rating with a $35 price target.....

Seems like a buying opportunity here to me.